GLP-1 Receptor Agonist Discontinuation Among Patients With Obesity and/or Type 2 Diabetes
Duy Ngoc, Tiffany Lee, Samuel K. Peasah, Chester B. Good, Angela Inneh, Urvashi Patel
Abstract
This cohort study examines the prevalence of and factors associated with glucagon-like peptide 1 agonist discontinuation among new users.
Topics & Concepts
DiscontinuationAgonistGlucagon-like peptide 1 receptorType 2 diabetesMedicineObesityDiabetes mellitusEndocrinologyInternal medicineCohortReceptorPharmacologyDiabetes Treatment and ManagementDiabetes Management and ResearchPharmacology and Obesity Treatment